BETA

IPO registrations (S-1, F-1) · Registrants

HARROW, INC.

SEC CIK
1360214 · filings on EDGAR ↗
Name on the registration
Imprimis Pharmaceuticals, Inc.
Former names
HARROW HEALTH, INC. (2018–2023); Imprimis Pharmaceuticals, Inc. (2012–2018); TRANSDEL PHARMACEUTICALS INC (2007–2012); Bywater Resources, Inc (2006–2007)
Registration
Form S-1, first filed 2008-02-07, last 2013-02-04; 1 initial registration, 6 amendments
Outcome
Final prospectus filed 2013-02-11; declared effective 2008-02-08
Industry (SIC)
Pharmaceutical Preparations 2834
Incorporated in
DE
Business address
1A BURTON HILLS BLVD, SUITE 200, Nashville, TN
EIN
45-0567010
Ticker
HROW (Nasdaq)
EDGAR entity type
operating
Insiders and CEO pay
HARROW, INC. on the corporate pages

Offering terms

Final price
$5.92 per share (424B4 filed 2013-02-11)
Shares sold
1,840,000
Gross proceeds
$10,902,000 before underwriting discounts and any over-allotment option
Listing
Nasdaq under the symbol IMMY
Lead underwriters
Aegis Capital

Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.

Filings 13

FiledFormWhat it isName as filedEDGAR
2008-02-07S-1/AS-1/A (amendment)TRANSDEL PHARMACEUTICALS INC0001144204-08-006682 ↗
2008-02-08EFFECTEFFECT (declared effective)TRANSDEL PHARMACEUTICALS INC9999999995-08-000471 ↗
2009-05-11EFFECTEFFECT (declared effective)TRANSDEL PHARMACEUTICALS INC9999999995-09-001371 ↗
2012-07-25S-1S-1 (registration)Imprimis Pharmaceuticals, Inc.0001354488-12-003649 ↗
2012-08-16S-1/AS-1/A (amendment)Imprimis Pharmaceuticals, Inc.0001354488-12-004307 ↗
2012-09-04S-1/AS-1/A (amendment)Imprimis Pharmaceuticals, Inc.0001354488-12-004684 ↗
2012-10-26S-1/AS-1/A (amendment)Imprimis Pharmaceuticals, Inc.0001354488-12-005456 ↗
2012-11-21S-1/AS-1/A (amendment)Imprimis Pharmaceuticals, Inc.0001354488-12-006129 ↗
2013-02-04S-1/AS-1/A (amendment)Imprimis Pharmaceuticals, Inc.0001354488-13-000399 ↗
2013-02-07S-1MEFS-1MEF (added securities)Imprimis Pharmaceuticals, Inc.0001078782-13-000264 ↗
2013-02-07EFFECTEFFECT (declared effective)Imprimis Pharmaceuticals, Inc.9999999995-13-000408 ↗
2013-02-11424B4424B4 (final prospectus)Imprimis Pharmaceuticals, Inc.0001354488-13-000537 ↗
2014-09-29EFFECTEFFECT (declared effective)Imprimis Pharmaceuticals, Inc.9999999995-14-002891 ↗

Prospectus pages read 2

FiledFormRead asRangePriceSharesProceedsListingUnderwritersWhat was foundDocument
2013-02-04S-1/Aregistration statement$5.921,619,047$9,592,853OTCQB IMMY1primary document; price line, shares headline, proceeds computed, cover names 1document ↗
2013-02-11424B4final prospectus$5.921,840,000$10,902,000Nasdaq IMMY1primary document; price line, shares headline, proceeds computed, cover names 1document ↗

Officers, directors and large holders Forms 3, 4 and 5

InsiderRoleTitleFilingsYearsOn this site
Abrams Family TrustTenPercentOwner12007
Abrams Jeffrey JDirector; Director,TenPercentOwner42007–2013person page Fuzzy
Brar BalbirDirector; OfficerVice President32007–2013
Lomoro John TOfficerChief Financial Officer32007–2009
Singh JulietDirector,Officer,TenPercentOwnerCEO, Director and President; President and CEO42007–2009
THORNLEY ANTHONY SDirector72007–2008
Finnegan PaulDirector; OfficerChief Medical Officer & COO42008–2013
SWANN LYNN CDirector22008
Schupp Joachim PHOfficerChief Medical Officer; CHIEF MEDICAL OFFICER62009–2013
NIDA TERRYOfficerChief Business Officer22010
BONFIGLIO JOHN NDirector,OfficerPresident and CEO22010
Boll AndrewOfficerChief Financial Officer; CHIEF FINANCIAL OFFICER; PRESIDENT AND CFO; VP, Accounting and Reporting; VP ACCOUNTING AND REPORTING312012–2026
Ladonnikov AlexejTenPercentOwner12012
BAUM MARK LDirector,Officer; Director,Officer,TenPercentOwnerChief Executive Officer; CHIEF EXECUTIVE OFFICER352012–2026
DERMASTAR INTERNATIONAL, LLCTenPercentOwner32012–2013
Kammer Robert JDirector; Director,Officer,TenPercentOwner; Director,TenPercentOwnerChairman of the Board; Chief Executive Officer342012–2021
AUSTIN STEPHEN GDirector102012–2020
Bassani August ShelbyDirector42012–2014
Professional Compounding Centers of America, Inc.TenPercentOwner12013
Miloni Donald PaulTenPercentOwner22013–2015
Kenny Peter CDirector22013
Nelson William H.Director42014–2016
LINDSTROM RICHARD L MDDirector162015–2022
SAHAREK JOHN P.OfficerCEO of ImprimisRx; CEO & President, ImprimisRx; Chief Commercial Officer; President, ImprimisRx172015–2025
Opaleye Management Inc.TenPercentOwner412015–2026
Principi AnthonyDirector82015–2020
Edwards Clayton DOfficerChief Operating Officer22017
Conrad BrettOther12018
Longboard Capital Advisors, LLCOther12018
Sparks TeresaDirector62020–2023
Van Horn R. LawrenceDirector62020–2023
Makary Martin A.Director62022–2024
Sternberg Perry J.Director62022–2026
Graves Adrienne LDirector62024–2026person page Fuzzy
SILVERNAIL LAUREN PDirector62024–2026
Shojaei AmirOfficerCHIEF SCIENTIFIC OFFICER42025–2026
Pollard Randall E.OfficerCHIEF ACCOUNTING OFFICER22025
Mullery Francis William JrOfficerCEO, ImprimisRx12025
Sullivan Patrick WilliamOfficerCHIEF COMMERCIAL OFFICER22026

Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.

Private offerings before or after (Form D)

First filedIssuerIndustryOfferingSoldInvestorsFilings
2021-05-14HARROW HEALTH, INC.Pharmaceuticals$10,670,000$10,670,00011
2016-12-30Imprimis Pharmaceuticals, Inc.Pharmaceuticals$10,068,740$10,068,7401431
2015-01-15Imprimis Pharmaceuticals, Inc.Pharmaceuticals$818,750$500,00021

Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.

Also on this site Fuzzy

RecordName as filedWhereDatasetMatched by
Form D issuerHARROW HEALTH, INC.TNForm D private offeringsCIK (EXACT)
SEC filerHARROW, INC.SEC filers (EDGAR)CIK (EXACT)
Form 5500 plan sponsorHARROW, INC.EIN (EXACT)
Lobbying clientHARROW INC.Federal lobbying (LDA)name and state
Person pageAdrienne L Graves PhdPeople (Form 990 officers, directors and employees)officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director)
Person pageJeffrey J AbramsPeople (Form 990 officers, directors and employees)officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director)

Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.

Others with the same interests

SIC industry Pharmaceutical Preparations, TN first:

More with this interest.

In other datasets, the same topic (Health) in TN:

Interests: Pharmaceutical Preparations · Health